Cancer research
Breakthrough in Lung Cancer Treatment: Genetically Engineered Nanoparticles Show Promise
Researchers from the Cell and Matrix Research Institute have published a new study on lung cancer, detailing the development of genetically engineered nanoparticles that demonstrate significant anti-tumor activity. The study, led by Sung-Min Kang, utilized natural killer (NK) cells to create small extracellular vesicles (sEVs) that possess inherent anti-tumor properties.